+ £20.00 Gift Aid
Thu 20 Apr 2023 - Sun 30 Apr 2023
IT3000, Supporting Football Shirt Friday to Tackle Bowel Cancer
Football Shirt Friday is an initiative that was started by the Bobby Moore Fund in the UK to raise funds for bowel cancer research. This year, on Friday 21st April, the Bobby Moore Fund is calling on people across the country to show their support by wearing their favourite football shirts, sharing selfies on social media using the hashtag #footballshirtfriday, and donating to the fund. As a company, we are proud to support this initiative and encourage all our employees to take part by wearing their favourite football shirt to work on Friday 21st April. Not only is this a fun way to show our support, but it is also an opportunity to raise awareness about bowel cancer and the importance of early detection. Bowel cancer is the fourth most common cancer in the UK, with over 42,000 new cases diagnosed each year. It is a disease that can affect anyone, regardless of age, gender, or lifestyle. However, if caught early, bowel cancer is highly treatable, and the chances of survival are greatly improved. By supporting Football Shirt Friday and donating to the Bobby Moore Fund, we can help fund pioneering research into the prevention, diagnosis, and treatment of bowel cancer. 100% of the money raised will go towards this important cause, so every donation counts.
Bobby Moore Fund
Bobby Moore was just 51 years old when he died. Shortly after his death in 1993, Bobby’s widow Stephanie Moore OBE set up the Bobby Moore Fund to raise money for pioneering bowel cancer research. Since the fund was set up , bowel cancer mortality rates have fallen by over 30%. However, with 46 people losing their life to the disease every day in the UK, we still have a long way to go.
With Cancer Research UK Giving Pages more of the money raised goes towards beating cancer. Aside from the credit and debit card fees, every penny donated goes to Cancer Research UK.
All donations made to this page will automatically be transferred to Cancer Research UK.